Toronto - Delayed Quote CAD

Medexus Pharmaceuticals Inc. (MDP.TO)

5.12 +0.20 (+4.07%)

At close: November 6 at 4:00:00 PM EST

Medexus Schedules Second Fiscal Quarter 2027 Conference Call

TMX Newsfile 5d ago

MDP.TO
+4.07%
MEDXF

P731.F
Medexus Eyes $175M GRAFAPEX Opportunity as Transplant Drug Gains Traction

MarketBeat 9d ago

MDP.TO
+4.07%
Medexus Holds Annual Meeting of Shareholders and Announces Election of Directors

TMX Newsfile 1mo ago

MDP.TO
+4.07%
MEDXF

P731.F
Medexus Pharmaceuticals Q1 Earnings Call Highlights

MarketBeat 2mo ago

MDP.TO
+4.07%
MDP.NE
Medexus Pharmaceuticals Inc (MEDXF) (Q1 2027) Earnings Call Highlights: Graphopex Surges 118% ...

GuruFocus.com 2mo ago
Medexus Schedules First Fiscal Quarter 2027 Conference Call

TMX Newsfile 3mo ago

MDP.TO
+4.07%
MDP.NE

P731.F
Medexus Announces Fiscal Year 2026 Results, Demonstrating Continued Momentum and Strong Product-Level Performance of GRAFAPEX (treosulfan) for Injection

TMX Newsfile 4mo ago

MDP.TO
+4.07%
MEDXF

P731.F
Medexus Announces License and Supply Deal for UM171 Cell Therapy in Canada

TMX Newsfile 4mo ago

MDP.TO
+4.07%
MEDXF

MDP.NE
Medexus Provides Business Update on GRAFAPEX (treosulfan) for Injection, Capital Allocation, and Investor Conference Participation

TMX Newsfile 6mo ago

MDP.TO
+4.07%
P731.F

MEDXF
Medexus Announces Fiscal Q1 2027 Results With Strongest Quarter of Product-Level Performance of GRAFAPEX (Treosulfan) to Date

TMX Newsfile 2mo ago

P731.F

MEDXF

MDP.TO
+4.07%
Medexus Schedules Fourth Fiscal Quarter and Fiscal Year 2026 Conference Call

TMX Newsfile 4mo ago

MDP.TO
+4.07%
MDP.NE

MEDXF
Medexus Pharmaceuticals Inc (MEDXF) Q4 2026 Earnings Call Highlights: Navigating Challenges and ...

GuruFocus.com 4mo ago

MDP.TO
+4.07%

U.S. markets closed

Medexus Pharmaceuticals Inc. (MDP.TO)

Medexus Schedules Second Fiscal Quarter 2027 Conference Call

Medexus Eyes $175M GRAFAPEX Opportunity as Transplant Drug Gains Traction

Medexus Holds Annual Meeting of Shareholders and Announces Election of Directors

Medexus Pharmaceuticals Q1 Earnings Call Highlights

Medexus Pharmaceuticals Inc (MEDXF) (Q1 2027) Earnings Call Highlights: Graphopex Surges 118% ...

Medexus Schedules First Fiscal Quarter 2027 Conference Call

Medexus Announces Fiscal Year 2026 Results, Demonstrating Continued Momentum and Strong Product-Level Performance of GRAFAPEX (treosulfan) for Injection

Medexus Announces License and Supply Deal for UM171 Cell Therapy in Canada

Medexus Provides Business Update on GRAFAPEX (treosulfan) for Injection, Capital Allocation, and Investor Conference Participation

Medexus Announces Fiscal Q1 2027 Results With Strongest Quarter of Product-Level Performance of GRAFAPEX (Treosulfan) to Date

Medexus Schedules Fourth Fiscal Quarter and Fiscal Year 2026 Conference Call

Medexus Pharmaceuticals Inc (MEDXF) Q4 2026 Earnings Call Highlights: Navigating Challenges and ...